Table 2 Procedural details, the postoperative course and information about the occurrence of perioperative myocardial infarction are depicted
Variable | Redo-OPCAB (n = 40) | Redo-ONCAB (n = 40) | p-value |
|---|---|---|---|
Operation time (min) | 195 ± 69 | 248 ± 40 | 0.01 |
Total arterial revascularization (n=) | 28 | 12 | 0.01 |
Bilateral internal mammary artery (BIMA) (n=) | 0.28 ± 0.45 | 0.30 ± 0.47 | 0.484 |
Radial artery | 0.15 ± 0.43 | 0.19 ± 0.40 | 0.821 |
Saphenic vein graft (n=) | 0.3 ± 0.48 | 0.85 ± 0.72 | 0.007 |
Single grafts (n=) | 1.05 ± 0.55 | 1.52 ± 1.16 | 0.06 |
Sequential grafts (n=) | 0.52 ± 0.55 | 0.62 ± 0.86 | 0.952 |
Total blood loss (ml) | 540 ± 494 | 867 ± 619 | 0.02 |
Transfusion of blood and/or derivatives (n=) | 11 | 9 | 0.53 |
Postoperative ventilation (hours) | 7 ± 8 | 9 ± 10 | 0.08 |
Intensive care stay (days) | 3 ± 2 | 5 ± 3 | 0.01 |
In-hospital stay (days) | 15 ± 10 | 13 ± 5 | 0.88 |
Cardiac ischemia markers (12 hours postop) | |||
CK (U/l) | 335 ± 341 | 709 ± 746 | 0.01 |
CK-MB (U/l) | 38 ± 45 | 30 ± 37 | 0.78 |
Troponin | 0.5 ± 0.5 | 5.3 ± 11 | 0.01 |
LDH | 208 ± 89 | 323 ± 135 | 0.01 |
Postoperative major cardiac adverse effects (n=) | 3 | 4 | 0.78 |
Impaired wound healing (%) | 7 ± 3 | 4 ± 2 | 0.15 |